2 results
Approved WMORecruiting
Primary: • Demonstrate superior efficacy (increased progression-free survival [PFS]) of MEK162 vs. physician*s choice of selected chemotherapies (liposomal doxorubicin, paclitaxel and topotecan)Key Secondary: • Demonstrate superior efficacy (…
Approved WMORecruiting
1. Effect evaluationTo assess the effectiveness of dynamic bracing on quality of life in patients suffering from an osteoporotic vertebral compression fracture (OVCF).2. Economic evaluationTo examine whether dynamic bracing compared to standard care…